arGEN-X Receives Two Preclinical Milestone Payments under Collaboration with Shire

arGEN-X, a clinical stage human therapeutic antibody company, today announces the attainment of two important success milestones in its SIMPLE Antibody™ research and product development collaboration with Shire.